Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan J Battermann

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2012
Comparison between external beam radiotherapy (70 Gy/74 Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patientsGregor Goldner, Richard Pötter, Jan J Battermann, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2010
Pretreatment nomogram to predict the risk of acute urinary retention after I-125 prostate brachytherapyEllen M Roeloffzen, Marco van Vulpen, Jan J Battermann, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2011
Prostate specific antigen bounce is related to overall survival in prostate brachytherapyKarel A Hinnen, Evelyn M Monninkhof, Jan J Battermann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 28, 2008
Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implantsMarinus A Moerland, Marijke J H van Deursen, Sjoerd G Elias, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostateEllen M A Roeloffzen, Evelyn M Monninkhof, Jan J Battermann, et al.
Anticancer Research|January 2, 2010
Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative studySherif Y El Sharouni, Henk B Kal, Angeliqué Barten-Van Rijbroek, et al.
BJU International|November 11, 2010
Survival after prostate brachytherapy in patients aged 60 years and youngerKarel A Hinnen, Ellen M A Roeloffzen, Jan J Battermann, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 2005
Treatment of stage III-IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2John J L Jacobs, Gerrit J Hordijk, Ina M Jürgenliemk-Schulz, et al.
European Urology|August 30, 2008
External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patientsIlze E W van Onna, Jorg R Oddens, Esther T Kok, et al.
International Journal of Radiation Oncology, Biology, Physics|July 10, 2010
Influence of dose on risk of acute urinary retention after iodine-125 prostate brachytherapyEllen M A Roeloffzen, Jan J Battermann, Marijke J H van Deursen, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2012
Comparison between external beam radiotherapy (70 Gy/74 Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patientsGregor Goldner, Richard Pötter, Jan J Battermann, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2010
Pretreatment nomogram to predict the risk of acute urinary retention after I-125 prostate brachytherapyEllen M Roeloffzen, Marco van Vulpen, Jan J Battermann, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2011
Prostate specific antigen bounce is related to overall survival in prostate brachytherapyKarel A Hinnen, Evelyn M Monninkhof, Jan J Battermann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 28, 2008
Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implantsMarinus A Moerland, Marijke J H van Deursen, Sjoerd G Elias, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostateEllen M A Roeloffzen, Evelyn M Monninkhof, Jan J Battermann, et al.
Anticancer Research|January 2, 2010
Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative studySherif Y El Sharouni, Henk B Kal, Angeliqué Barten-Van Rijbroek, et al.
BJU International|November 11, 2010
Survival after prostate brachytherapy in patients aged 60 years and youngerKarel A Hinnen, Ellen M A Roeloffzen, Jan J Battermann, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 2005
Treatment of stage III-IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2John J L Jacobs, Gerrit J Hordijk, Ina M Jürgenliemk-Schulz, et al.
European Urology|August 30, 2008
External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patientsIlze E W van Onna, Jorg R Oddens, Esther T Kok, et al.
International Journal of Radiation Oncology, Biology, Physics|July 10, 2010
Influence of dose on risk of acute urinary retention after iodine-125 prostate brachytherapyEllen M A Roeloffzen, Jan J Battermann, Marijke J H van Deursen, et al.
Pageof 4